Archives of Medical Research
Volume 41, Issue 3 , Pages 162-169, April 2010

Sensitization of Osteosarcoma Cell Line SaOS-2 to Chemotherapy by Downregulating Survivin

  • Jun Zou

      Affiliations

    • Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
    • These authors contributed equally to this work.
  • ,
  • Minfeng Gan

      Affiliations

    • Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
    • These authors contributed equally to this work.
  • ,
  • Nana Mao

      Affiliations

    • Department of Pharmacy, Suzhou School of Medial Science and Technology, Suzhou, Jiangsu, China
  • ,
  • Xuesong Zhu

      Affiliations

    • Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • ,
  • Qin Shi

      Affiliations

    • Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • ,
  • Huilin Yang

      Affiliations

    • Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
    • Corresponding Author InformationAddress reprint requests to: Huilin Yang, MD, Chairman & Professor, Department of Orthopaedic Surgery, The First Affiliated Hospital of Soochow University, 188 Shizi St., Suzhou, Jiangsu 215006, China; Phone: +86-512-67780101; FAX: +86-512-67780999

Received 24 September 2009; accepted 7 February 2010.

(ARCMED-D-09-00448)

Background and Aims

Osteosarcoma is the most frequent malignant bone tumor with a peak incidence in the second and third decades of life. Survivin, a member of the IAP family of proteins, is overexpressed in osteosarcomas and plays an important role in protecting cells from apoptosis. Here we investigated the anti-cancer effects of downregulating survivin by shRNA vector pSUPER-sh in combination with chemotherapeutic drugs on human osteosarcoma cells.

Methods

Expression of survivin was detected by Western blot. The effects of pSUPER-sh and chemotherapeutic drugs on osteosarcoma cell lines Saos-2 and U2OS by cell viability assay and its underlying mechanisms were analyzed by flow cytometry and caspase-3 activity assay.

Results

Downregulated survivin could significantly induce apoptosis of osteosarcoma cell lines Saos-2 and U2OS. The effect probably resulted from downregulation of survivin induced by pSUPER-sh. Importantly, we found that the downregulation of survivin by pSUPER-sh could enhance the anticancer effects of chemotherapies such as etoposide, cisplatin and doxorubicin through decreasing mitochondrial membrane potentials and increasing caspase-3 activity.

Conclusions

Downregulated survivin by pSUPER-sh could markedly induce apoptosis of osteosarcoma cells lines and pSUPER-sh may be a promising adjuvant in osteosarcoma chemotherapy.

Key Words: Osteosarcoma, Survivin, Chemotherapy, Sensitization

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0188-4409(10)00097-4

doi:10.1016/j.arcmed.2010.04.006

Archives of Medical Research
Volume 41, Issue 3 , Pages 162-169, April 2010